RECRUITING

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Official Title

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Quick Facts

Study Start:2024-07-15
Study Completion:2029-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06461962

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient-defined regular use of methamphetamine in the last year
  2. * Any methamphetamine use in the past 30 days
  3. * Age 18 years or older
  4. * No client-reported diagnosis of heart failure
  5. * Able to communicate in English
  6. * Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms
  1. * Self-reported engagement in medical care for heart failure in past 6 months.
  2. * Actively taking medications for heart failure.

Contacts and Locations

Study Contact

Brian Chan, MD, MPH
CONTACT
503-494-2010
chanbri@ohsu.edu
Kellie Pertl, MPH
CONTACT
pertl@ohsu.edu

Principal Investigator

Brian Chan, MD, MPH
PRINCIPAL_INVESTIGATOR
Oregon Health and Science University

Study Locations (Sites)

Oregon Health & Science University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

  • Brian Chan, MD, MPH, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-15
Study Completion Date2029-06-30

Study Record Updates

Study Start Date2024-07-15
Study Completion Date2029-06-30

Terms related to this study

Keywords Provided by Researchers

  • Screening
  • Implementation Science
  • Heart Failure
  • Addiction
  • Stimulants
  • Health Services
  • Community Engaged Research

Additional Relevant MeSH Terms

  • Methamphetamine Use
  • Heart Failure